Neuronetics (STIM) EPS (Basic) (QoQ) (2017 - 2026)
Neuronetics (STIM) EPS (Basic) (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Neuronetics | 226.33 Mn | 206.90 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.07% |
| Mar 31, 2026 | -43.56% |
| Dec 31, 2025 | 37.29% |
| Sep 30, 2025 | 34.61% |
| Jun 30, 2025 | -29.10% |
| Mar 31, 2025 | 51.24% |
| Dec 31, 2024 | -39.82% |
| Sep 30, 2024 | 11.55% |
| Jun 30, 2024 | -19.82% |
| Mar 31, 2024 | -38.51% |
| Dec 31, 2023 | 38.90% |
| Sep 30, 2023 | -19.24% |
| Jun 30, 2023 | 26.64% |
| Mar 31, 2023 | -21.32% |
| Dec 31, 2022 | -1.54% |
| Sep 30, 2022 | 21.94% |
| Jun 30, 2022 | 27.90% |
| Mar 31, 2022 | -88.96% |
| Dec 31, 2021 | 37.53% |
| Sep 30, 2021 | 50.25% |